Major adverse cardiovascular events

Cross-source consensus on Major adverse cardiovascular events from 1 sources and 5 claims.

1 sources · 5 claims

Risks & contraindications

Thirty-day MACE occurred in 4.6% of the cohort. — N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study
The dual-positive biomarker group had the highest observed 30-day MACE rate. — N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study
Arrhythmias were a major component of postoperative cardiovascular risk. — N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study
Some MACE events occurred without dual biomarker elevation, so biomarker status did not capture all events. — N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study
Among patients with MACE, hypertension and smoking were each present in 77% of cases. — N-terminal proBNP adds prognostic value to high-sensitivity cardiac troponin I in elective thoracic surgery: an observational cohort study